Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran

Objectives: To assess the comparative budget and health impact of lower-dose dabigatran versus reduced doses of apixaban and rivaroxaban in atrial fibrillation (AF) patients eligible for a lower-/reduced-dose due to individual patient characteristics in the Netherlands. Methods: A budget impact mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Fens, Tanja, de Jong, Lisa, Kappelhoff, Bregt, Boersma, Cornelis, Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478629/
https://www.ncbi.nlm.nih.gov/pubmed/37675057
http://dx.doi.org/10.1080/20016689.2023.2247719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478629/
https://www.ncbi.nlm.nih.gov/pubmed/37675057
http://dx.doi.org/10.1080/20016689.2023.2247719

Ejemplares similares